China’s NHC Launches Pilot Plan to Expand Wholly Foreign-Owned Hospital Sector
The National Health Commission (NHC) has released the “Pilot Work Plan for Expanding the Wholly...
NHSA (prev. SMIA)
National Reimbursement Drug List 2024 Expands Coverage with 91 New Drugs
The National Medical Products Administration has released the finalized National Reimbursement Drug List (NRDL) for...
NHSA Issues Guidelines to Suspend Direct Online Listing of In-Shortage Drugs
The National Healthcare Security Administration (NHSA) has issued the “Guidelines for Risk Management of In-Shortage...
NHSA to Announce NRDL Adjustment Results at November 28th Press Conference
The National Healthcare Security Administration (NHSA) will unveil the results of the negotiation and price...
NMPA Launches ‘Medical Service Price Items’ Column with Comprehensive Sub-Sections
The National Medical Products Administration (NMPA) has taken a significant step towards enhancing transparency in...
NHSA and MoF Announce Medical Insurance Fund Prepayment Initiative to Aid Healthcare Institutions
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly issued...
NHSA and MCA Boost Medical Assistance with Enhanced Information Sharing Measures
The National Healthcare Security Administration (NHSA) and the Ministry of Civil Affairs (MCA) have jointly...
China’s NHSA Sets October Dates for National Reimbursement Drug List Negotiations and Price Bidding
The National Healthcare Security Administration (NHSA) has announced that the one-site negotiation and price bidding...
China’s NHSA Concludes Pre-Negotiation Talks for National Reimbursement Drug List
According to the Economic Observer, an independent Chinese weekly newsletter, a series of discussions preceding...
NHSA Standardizes NRDL Drug Purchases to Combat Prescription Fraud
The National Healthcare Security Administration (NHSA) has issued a notification aimed at standardizing the management...
China’s National Healthcare Security Administration Issues Draft Guidelines for Long-Term Care Insurance
The National Healthcare Security Administration (NHSA) has released the “Draft Technical Guidelines for the Preparation...
China Unveils Medical Insurance Eligibility Management System for Designated Healthcare Personnel
The National Healthcare Security Administration (NHSA), National Health Commission, and National Medical Products Administration (NMPA)...
NHSA Concludes 2024 NRDL Review, Announces Submission Deadlines for Drug Manufacturers
The National Healthcare Security Administration (NHSA) has declared the completion of the expert review process...
China’s NHSA and MOF Issue Notices to Enhance Cross-Regional Medical Treatment Direct Settlement
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MOF) have issued two...
China’s NHSA Proposes New Guidelines to Enhance Oversight of Medical Insurance Funds
The National Healthcare Security Administration (NHSA) has unveiled a draft of the “Guiding Opinions on...
China to Enhance Basic Medical Insurance Coverage for Residents in 2024 with Increased Subsidies and Personal Payments
The National Healthcare Security Administration (NHSA), in conjunction with the Ministry of Finance and State...
NHSA Flags Concerns Over Pricing of MicroPort’s Castor Aortic Stent Graft System
BEIJING—The National Healthcare Security Administration (NHSA) has issued an open letter expressing concerns over the...
NHSA Preliminary Review Identifies Potential NRDL Additions, Including Novel Therapies and ADCs
The National Healthcare Security Administration (NHSA) has released a preliminary list of drugs that have...
China’s NHSA and NHC to Integrate Village Clinics into Basic Medical Insurance System
The National Healthcare Security Administration (NHSA) and the National Health Commission (NHC) of China have...
NHSA Report: China’s Medical Insurance Fund Records Significant Growth and Savings in 2023
The National Healthcare Security Administration (NHSA) has released its comprehensive annual statistical report for the...